Showing results (111-120 of 163) with videos related to
Sort By:
Pageof 17
Carcinogenesis|November 21, 2014
Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancerJunji Kurashige, Kosuke Mima, Genta Sawada, et al.Plos One|July 31, 2012
N-myc downstream regulated gene 1 (NDRG1) promotes metastasis of human scirrhous gastric cancer cells through epithelial mesenchymal transitionHiroki Ureshino, Yuichi Murakami, Kosuke Watari, et al.Scientific Reports|September 13, 2017
Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis resistance through different mechanisms in scirrhous gastric cancer cell linesKoichi Baba, Yoshihiko Kitajima, Shuusuke Miyake, et al.Anticancer Research|March 6, 2020
ADAR2 Regulates Malignant Behaviour of Mesothelioma Cells Independent of RNA-editing ActivityKen-Ichiro Sakata, Kojiro Maeda, Nozomi Sakurai, et al.Oncogene|May 31, 2002
Restoration of E-cadherin-based cell-cell adhesion by overexpression of nectin in HSC-39 cells, a human signet ring cell gastric cancer cell lineYing-Feng Peng, Kenji Mandai, Hiroyuki Nakanishi, et al.Investigational New Drugs|April 24, 2009
Suppression of in vivo tumor growth by using a biodegradable thermosensitive hydrogel polymer containing chemotherapeutic agentMi Kyung Kwak, Keun Hur, Ji Eun Yu, et al.Human Cell|December 8, 2024
Establishment and characterization of a novel patient-derived cell line from conventional central grade 3 chondrosarcoma, NCC-CS1-C1Rei Noguchi, Takuya Ono, Julia Osaki, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 14, 2004
Aberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancerMasako Ueno, Minoru Toyota, Kimishige Akino, et al.Frontiers in Pharmacology|October 30, 2018
Metabolic Characterization of Antifolate Responsiveness and Non-responsiveness in Malignant Pleural Mesothelioma CellsYuzo Sato, Shiori Matsuda, Ami Maruyama, et al.Molecular Cancer Therapeutics|April 22, 2010
Identification of c-Src as a potential therapeutic target for gastric cancer and of MET activation as a cause of resistance to c-Src inhibitionWataru Okamoto, Isamu Okamoto, Takeshi Yoshida, et al.Pageof 17